{"AllianceGenome": "10586", "HGNC": "10586", "MIM": "600235", "_id": "6324", "_version": 1, "accession": {"genomic": ["AC020907.6", "AH005825.3", "CP068259.2", "DQ677665.1", "L48689.1", "NC_000019.10", "NC_060943.1", "NG_013359.1"], "protein": ["AAA60391.1", "AAA61277.1", "AAB97608.1", "AAC41946.1", "AAH21266.2", "AAH67122.1", "AAI12923.1", "AAR25552.1", "AAV38726.1", "ABQ01236.1", "BAG36087.1", "BAG58404.1", "NP_001028.1", "NP_001308534.1", "NP_950238.1", "Q07699.1"], "rna": ["AK295477.1", "AK313279.1", "AY391842.1", "BC021266.2", "BC030193.1", "BC067122.1", "BC112922.1", "BF194996.1", "BM805468.1", "BT019923.1", "DA062026.1", "L10338.1", "L16242.1", "NM_001037.5", "NM_001321605.2", "NM_199037.5"], "translation": [{"protein": "NP_950238.1", "rna": "NM_199037.5"}, {"protein": "BAG58404.1", "rna": "AK295477.1"}, {"protein": "AAH67122.1", "rna": "BC067122.1"}, {"protein": "AAV38726.1", "rna": "BT019923.1"}, {"protein": "AAH21266.2", "rna": "BC021266.2"}, {"protein": "AAI12923.1", "rna": "BC112922.1"}, {"protein": "AAA61277.1", "rna": "L16242.1"}, {"protein": "BAG36087.1", "rna": "AK313279.1"}, {"protein": "NP_001028.1", "rna": "NM_001037.5"}, {"protein": "NP_001308534.1", "rna": "NM_001321605.2"}, {"protein": "AAA60391.1", "rna": "L10338.1"}, {"protein": "AAR25552.1", "rna": "AY391842.1"}]}, "alias": ["ATFB13", "BRGDA5", "DEE52", "EIEE52", "GEFSP1"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2022-01-04T21:10:51.949Z", "disease_label": "developmental and epileptic encephalopathy", "gcep": "Epilepsy Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0100062", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4c35c20-6e59-46cf-9347-852b80af8dcc-2022-01-04T211051.949Z", "sop": "SOP8"}, {"classification": "definitive", "classification_date": "2022-12-13T17:00:00.000Z", "disease_label": "generalized epilepsy with febrile seizures plus", "gcep": "Epilepsy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0018214", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-2022-12-13T170000.000Z", "sop": "SOP9"}, {"classification": "disputed", "classification_date": "2017-11-21T00:00:00", "disease_label": "Brugada syndrome 1", "gcep": "Brugada Syndrome Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0011001", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGCIEX:assertion_10158", "sop": "SOP5"}]}, "ensembl": {"gene": "ENSG00000105711", "protein": ["ENSP00000262631", "ENSP00000396915", "ENSP00000468848", "ENSP00000492022", "ENSP00000492247", "ENSP00000492655", "ENSP00000502395", "ENSP00000502717"], "transcript": ["ENST00000262631", "ENST00000415950", "ENST00000595652", "ENST00000596348", "ENST00000602150", "ENST00000638536", "ENST00000639260", "ENST00000640135", "ENST00000675741", "ENST00000676410"], "translation": [{"protein": "ENSP00000396915", "rna": "ENST00000415950"}, {"protein": "ENSP00000262631", "rna": "ENST00000262631"}, {"protein": "ENSP00000492022", "rna": "ENST00000638536"}, {"protein": "ENSP00000468848", "rna": "ENST00000595652"}, {"protein": "ENSP00000492655", "rna": "ENST00000640135"}, {"protein": "ENSP00000492247", "rna": "ENST00000596348"}, {"protein": "ENSP00000502717", "rna": "ENST00000676410"}, {"protein": "ENSP00000502395", "rna": "ENST00000675741"}], "type_of_gene": "protein_coding"}, "entrezgene": "6324", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 6.61725735, "exp_mis": 116.8676619, "exp_syn": 50.01719, "lof_z": 1.77801219455376, "mis_z": 2.12052219536008, "mu_lof": 5.39682777764e-07, "mu_mis": 1.08039217413e-05, "mu_syn": 4.74724765309e-06, "n_lof": 2.0, "n_mis": 70.0, "n_syn": 37.0, "p_li": 0.205166938448244, "p_null": 0.042659747209085, "p_rec": 0.752173314342671, "syn_z": 1.14105626881838}, "bp": 807, "cds_end": 35525002, "cds_start": 35521724, "n_exons": 3, "nonpsych": {"exp_lof": 5.9479854, "exp_mis": 105.7352435, "exp_syn": 45.2291127, "lof_z": 1.58980025400501, "mis_z": 2.04717208102297, "mu_lof": 5.39682777764e-07, "mu_mis": 1.08039217413e-05, "mu_syn": 4.74724765309e-06, "n_lof": 2.0, "n_mis": 64.0, "n_syn": 31.0, "p_li": 0.183600414363882, "p_null": 0.0615473556155914, "p_rec": 0.754852230020526, "syn_z": 1.3320858323638}, "nontcga": {"exp_lof": 6.08385424, "exp_mis": 107.514234, "exp_syn": 46.01179432, "lof_z": 2.03322271735454, "mis_z": 2.18687560478602, "mu_lof": 5.39682777764e-07, "mu_mis": 1.08039217413e-05, "mu_syn": 4.74724765309e-06, "n_lof": 1.0, "n_mis": 62.0, "n_syn": 36.0, "p_li": 0.539623522085336, "p_null": 0.0146703811873715, "p_rec": 0.445706096727293, "syn_z": 0.934543423828778}, "transcript": "ENST00000415950.3"}, "exons": [{"cdsend": 35039701, "cdsstart": 35030820, "chr": "19", "position": [[35030469, 35030860], [35032527, 35032694], [35033498, 35033739], [35039116, 35039258], [35039634, 35039706], [35039796, 35040449]], "strand": 1, "transcript": "NM_001037", "txend": 35040449, "txstart": 35030469}, {"cdsend": 35039701, "cdsstart": 35032586, "chr": "19", "position": [[35031270, 35031780], [35032527, 35032694], [35033498, 35033739], [35039116, 35039258], [35039634, 35039706], [35039796, 35040449]], "strand": 1, "transcript": "NM_001321605", "txend": 35040449, "txstart": 35031270}, {"cdsend": 35034098, "cdsstart": 35030820, "chr": "19", "position": [[35030469, 35030860], [35032527, 35032694], [35033498, 35037720]], "strand": 1, "transcript": "NM_199037", "txend": 35037720, "txstart": 35030469}], "exons_hg19": [{"cdsend": 35530605, "cdsstart": 35521724, "chr": "19", "position": [[35521373, 35521764], [35523431, 35523598], [35524402, 35524643], [35530020, 35530162], [35530538, 35530610], [35530700, 35531353]], "strand": 1, "transcript": "NM_001037", "txend": 35531353, "txstart": 35521373}, {"cdsend": 35530605, "cdsstart": 35523490, "chr": "19", "position": [[35522174, 35522684], [35523431, 35523598], [35524402, 35524643], [35530020, 35530162], [35530538, 35530610], [35530700, 35531353]], "strand": 1, "transcript": "NM_001321605", "txend": 35531353, "txstart": 35522174}, {"cdsend": 35525002, "cdsstart": 35521724, "chr": "19", "position": [[35521373, 35521764], [35523431, 35523598], [35524402, 35528624]], "strand": 1, "transcript": "NM_199037", "txend": 35528624, "txstart": 35521373}], "generif": [{"pubmed": 12011299, "text": "Mutation of the sodium channel subunit SCN1B linked again to generalized epilepsy with febrile seizures"}, {"pubmed": 12486163, "text": "Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1."}, {"pubmed": 12677453, "text": "the expression of NaCh beta1 subunit protein in astrocytes is plastic, and indicate a novel mechanism for modulation of glial function in gliosis-associated pathologies."}, {"pubmed": 14504340, "text": "The IVS2-2A>C transition deletes AA 70-74 in the central hydrophobic core of the extracellular Ig domain, disrupting the hydrophobic interaction in the Ig-like fold & proper [beta]1 folding & causing a persistent inward Na+ current & hyperexcitability."}, {"pubmed": 14622265, "text": "identification and characterization of a novel splicing variant; functional studies in oocytes demonstrate that the beta1B subunit increases the ionic current when coexpressed with the tetrodotoxin sensitive channel, NaV1.2"}, {"pubmed": 16052353, "text": "Although data suggest that SCN1B activity does not directly influence membrane potential, intracellular Ca(2+) release, or proliferation in normal human pulmonary artery smooth muscle cells, its physiological functions remain unresolved."}, {"pubmed": 16205844, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17604911, "text": "Use of these Na+ channel models in simple neuron models revealed that both mutations(R85C, R85H) cause an increase in excitability but the R85H mutation was more excitable."}, {"pubmed": 17629415, "text": "In summary, the mutant beta1 subunits essentially fail to modulate alpha subunits which could increase neuronal excitability and underlie GEFS+ pathogenesis."}, {"pubmed": 17927801, "text": "This suggests that mutations in the SCN1B gene is not a prevalent cause of familial cases of FS and epilepsy or GEFS+ in Scandinavia."}, {"pubmed": 18052691, "text": "SCN1B mutations were not found to directly cause long QT syndrome."}, {"pubmed": 18093548, "text": "In patient with epilepsy were carried the mutation (C121W) of SCN1B."}, {"pubmed": 18175077, "text": "Febrile Seizure is not related to the most common mutations of SCN1B in two Tunisian families"}, {"pubmed": 18464934, "text": "SCN1B may have a role in human arrhythmia susceptibility"}, {"pubmed": 18755274, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19270815, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19522081, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19710327, "text": "The data of this study suggested that SCN1B p.R125C is an autosomal recessive cause of Dravet syndrome through functional gene inactivation."}, {"pubmed": 19808477, "text": "Loss of function mutations in sodium channel beta-subunits were identified in patients with atrial fibrillation and were associated with a distinctive ECG phenotype"}, {"pubmed": 19808477, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19861310, "text": "Enhanced tubulin polymerization reduces sarcolemmal Na(v)1.5 expression and I(Na) amplitude in a beta1-subunit-independent fashion and causes I(Na) fast and slow inactivation impairment in a beta1-subunit-dependent way"}, {"pubmed": 20137763, "text": "The IVS3+ 2996(TTA)8 allele in SCN1B commonly seen in Japanese would not be pathogenic itself but may render male, middle-aged Japanese more susceptible to Brugada syndrome"}, {"pubmed": 20226894, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20602612, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21040232, "text": "SCN1B is the gene responsible in one out of six Tunisian families with febrile seizures (FS) that may contribute susceptibility for the five others."}, {"pubmed": 21882141, "text": "This study demonstrated that SCN1B may not be related to the occurrence of benign partial epilepsy in infancy or convulsions with gastroenteritis."}, {"pubmed": 21994374, "text": "The results suggested that beta1B p.G257R may contribute to epilepsy through a mechanism that includes intracellular retention resulting in aberrant neuronal pathfinding."}, {"pubmed": 22011963, "text": "Mutation analysis of the SCN1B, SCN1A and GABRG2 genes in children affected by Genetic (Generalised) Epilepsy with Febrile Seizures plus was performed"}, {"pubmed": 22155597, "text": "results suggest that R214Q variation in SCN1Bb is a functional polymorphism that may serve as a modifier of the substrate responsible for Brugada syndrome or SIDS phenotypes"}, {"pubmed": 22284586, "text": "Our study supports the association of SCN1Bb with BrS."}, {"pubmed": 22292491, "text": "A novel seizure-causing mechanism is suggested for NaV1.2beta1 in patients harboring mutant C121W subunit: increased channel excitability at elevated temperature."}, {"pubmed": 23182416, "text": "SCN1B mutation is not a common cause of Dravet syndrome."}, {"pubmed": 24337656, "text": "sodium channel polymorphisms are associated with epilepsy"}, {"pubmed": 24561865, "text": "experimental data indicate that sodium channel voltage-gated type I beta subunit (Navbeta1b)/H162P results in reduced sodium channel activity functionally affecting the ventricular action potential."}, {"pubmed": 24605816, "text": "Hippocampal networks of a NaV beta1 transgenic mouse model of genetic epilepsy show enhanced excitability."}, {"pubmed": 24662403, "text": "data revealed SCN1Bb as a susceptibility gene responsible for LQTS"}, {"pubmed": 24729314, "text": "High SCN1B expression is associated with increased tumour growth and metastasis in breast cancer."}, {"pubmed": 25421039, "text": "Study showed that the human SCN1B C121W epilepsy mutation leads to decreased axon initial segments expression of SCN1B in heterozygous CW mice and a complete lack of SCN1B in homozygous WW mice"}, {"pubmed": 25757662, "text": "In a nonreferred nationwide Danish cohort of SIDS cases, up to 5/66 (7.5%) of SIDS cases can be explained by genetic variants in the sodium channel complex genes."}, {"pubmed": 25998140, "text": "SCN1B gene mutations that reduce sodium channel current may provide a mechanistic link between Atrioventricular nodal reentrant tachycardia and Brugada syndrome and predispose to expression of both phenotypes."}, {"pubmed": 26129877, "text": "We also identified an SCN1B T189M variant in 2 probands with lone AF and in 1 of 250 control subjects."}, {"pubmed": 26179811, "text": "Contribution of Cardiac Sodium Channel beta-Subunit Variants to Brugada Syndrome."}, {"pubmed": 28218389, "text": "we confirm the recessive inheritance of 2 novel SCN1B mutations in 5 children from 3 families with developmental epileptic encephalopathy. The recessive inheritance and early death in these patients is consistent with the Dravet-like phenotype observed in Scn1b(-/-) mice."}, {"pubmed": 28566192, "text": "This report provides the first genetic evidence of SCN1B mutation causing the Benign Familial Infantile Epilepsy (BFIE) phenotype."}, {"pubmed": 28681755, "text": "Genetic analysis was suggestive of SCN1B gene mutation associated with Dravet syndrome"}, {"pubmed": 28878239, "text": "results show that the primary defect of E87Q mutation of the beta1 subunit is to compromise the correct voltage gated sodium channel maturation and traffic"}, {"pubmed": 29758173, "text": "The lack of genotype-phenotype concordance among families, combined with the high frequency of previously reported mutations in the Genome Aggregation Database browser, suggests that SCN1B is not a monogenic cause of BrS or SADS."}, {"pubmed": 29992740, "text": "our results show that the role of beta1 subunit on the maturation and expression of the entire NaCh complex is of paramount importance to understand the pathological conditions resulted from a defective interaction between the NaCh constituents."}, {"pubmed": 30160358, "text": "The S248R and R250T mutations of SCN1Bbeta gene caused gain-of-function of Ito by associated with Kv4.3, which maybe underlie the early repolarization syndrome (ERS) phenotype of the probands."}, {"pubmed": 30386899, "text": "Scn1b and Fxyd1 expression was significantly downregulated in HSCR colon."}, {"pubmed": 30765606, "text": "this study reports the cryo-electron microscopy structures of the human Nav1.7-beta1-beta2 complex bound to two combinations of pore blockers and gating modifier toxins (GMTs), tetrodotoxin with protoxin-II and saxitoxin with huwentoxin-IV, both determined at overall resolutions of 3.2 angstroms."}, {"pubmed": 31729702, "text": "The sequencing analyses of the SCN1B gene revealed the presence of a new pathogenic variation c.374C>T (p.R125L) in family A and a putative disease-associated haplotype in five families. Using multiple alignments, the c.374G>T changed a highly conserved arginine to a leucine p.R125L located in the extracellular domain of the protein."}, {"pubmed": 32503841, "text": "Sodium channel beta1 subunits are post-translationally modified by tyrosine phosphorylation, S-palmitoylation, and regulated intramembrane proteolysis."}, {"pubmed": 33901312, "text": "Homozygous SCN1B variants causing early infantile epileptic encephalopathy 52 affect voltage-gated sodium channel function."}, {"pubmed": 35603785, "text": "Neonatal Scn1b-null mice have sinoatrial node dysfunction, altered atrial structure, and atrial fibrillation."}, {"pubmed": 35801810, "text": "Association of sodium voltage-gated channel genes polymorphisms with epilepsy risk and prognosis in the Saudi population."}, {"pubmed": 38139087, "text": "Impact of rs1805127 and rs55742440 Variants on Atrial Remodeling in Hypertrophic Cardiomyopathy Patients with Atrial Fibrillation: A Romanian Cohort Study."}], "genomic_pos": {"chr": "19", "end": 35040449, "ensemblgene": "ENSG00000105711", "start": 35030470, "strand": 1}, "genomic_pos_hg19": {"chr": "19", "end": 35531352, "start": 35521588, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0007155", "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007411", "qualifier": "involved_in", "term": "axon guidance"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010765", "pubmed": 19808477, "qualifier": "involved_in", "term": "positive regulation of sodium ion transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010976", "qualifier": "involved_in", "term": "positive regulation of neuron projection development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0019227", "qualifier": "involved_in", "term": "neuronal action potential propagation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021966", "qualifier": "involved_in", "term": "corticospinal neuron axon guidance"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035725", "pubmed": [18464934, 19808477, 21051419], "qualifier": "involved_in", "term": "sodium ion transmembrane transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0040011", "qualifier": "involved_in", "term": "locomotion"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051899", "pubmed": 21051419, "qualifier": "involved_in", "term": "membrane depolarization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060048", "pubmed": 19808477, "qualifier": "involved_in", "term": "cardiac muscle contraction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060307", "pubmed": 17884088, "qualifier": "involved_in", "term": "regulation of ventricular cardiac muscle cell membrane repolarization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060371", "pubmed": [19808477, 22247482], "qualifier": "involved_in", "term": "regulation of atrial cardiac muscle cell membrane depolarization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0061337", "qualifier": "involved_in", "term": "cardiac conduction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0086002", "qualifier": "involved_in", "term": "cardiac muscle cell action potential involved in contraction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0086002", "pubmed": 19808477, "qualifier": "involved_in", "term": "cardiac muscle cell action potential involved in contraction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0086012", "pubmed": 17884088, "qualifier": "involved_in", "term": "membrane depolarization during cardiac muscle cell action potential"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0086047", "pubmed": 18464934, "qualifier": "involved_in", "term": "membrane depolarization during Purkinje myocyte cell action potential"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0086091", "qualifier": "involved_in", "term": "regulation of heart rate by cardiac conduction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0086091", "pubmed": 19808477, "qualifier": "involved_in", "term": "regulation of heart rate by cardiac conduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1905152", "pubmed": 36696443, "qualifier": "involved_in", "term": "positive regulation of voltage-gated sodium channel activity"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:2000649", "qualifier": "involved_in", "term": "regulation of sodium ion transmembrane transporter activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000649", "pubmed": 19808477, "qualifier": "involved_in", "term": "regulation of sodium ion transmembrane transporter activity"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0001518", "qualifier": "part_of", "term": "voltage-gated sodium channel complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0001518", "pubmed": [8125980, 19808477, 21051419, 30190309, 36696443, 36823201], "qualifier": "part_of", "term": "voltage-gated sodium channel complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [19710327, 30190309], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0014704", "qualifier": "located_in", "term": "intercalated disc"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0030315", "qualifier": "located_in", "term": "T-tubule"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0033268", "qualifier": "located_in", "term": "node of Ranvier"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043204", "qualifier": "located_in", "term": "perikaryon"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0005248", "pubmed": 19808477, "qualifier": "enables", "term": "voltage-gated sodium channel activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [26900580, 30190309], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0017080", "pubmed": [8125980, 18464934, 19710327, 19808477, 36696443], "qualifier": "enables", "term": "sodium channel regulator activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0019871", "qualifier": "enables", "term": "sodium channel inhibitor activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0019871", "pubmed": 17884088, "qualifier": "enables", "term": "sodium channel inhibitor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0044325", "qualifier": "enables", "term": "transmembrane transporter binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0086006", "pubmed": 19808477, "qualifier": "enables", "term": "voltage-gated sodium channel activity involved in cardiac muscle cell action potential"}, {"category": "MF", "evidence": "IMP", "id": "GO:0086062", "pubmed": 18464934, "qualifier": "enables", "term": "voltage-gated sodium channel activity involved in Purkinje myocyte action potential"}]}, "homologene": {"genes": [[7955, 555423], [7955, 100005325], [8364, 101734970], [9544, 707134], [9598, 747705], [9606, 6324], [9615, 484584], [9913, 618204], [10090, 20266], [10116, 29686]], "id": 810}, "interpro": [{"desc": "Immunoglobulin V-set domain", "id": "IPR013106", "short_desc": "Ig_V-set"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Sodium channel subunit beta-1/beta-3", "id": "IPR027098", "short_desc": "Na_channel_b1/b3"}, {"desc": "Immunoglobulin-like domain superfamily", "id": "IPR036179", "short_desc": "Ig-like_dom_sf"}], "ipi": ["IPI00018980", "IPI00909588"], "map_location": "19q13.11", "name": "sodium voltage-gated channel beta subunit 1", "other_names": ["sodium channel subunit beta-1", "sodium channel, voltage gated, type I beta subunit", "sodium channel, voltage-gated, type I, beta"], "pantherdb": {"HGNC": "10586", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "98247", "ortholog_type": "LDO", "panther_family": "PTHR10546", "taxid": 10090, "uniprot_kb": "P97952"}, {"RGD": "3631", "ortholog_type": "LDO", "panther_family": "PTHR10546", "taxid": 10116, "uniprot_kb": "Q00954"}, {"Ensembl": "ENSGALG00000047060", "ortholog_type": "LDO", "panther_family": "PTHR10546", "taxid": 9031, "uniprot_kb": "A0A3Q2TW18"}, {"ZFIN": "ZDB-GENE-060503-783", "ortholog_type": "O", "panther_family": "PTHR10546", "taxid": 7955, "uniprot_kb": "A8E7Q8"}, {"ZFIN": "ZDB-GENE-090408-1", "ortholog_type": "LDO", "panther_family": "PTHR10546", "taxid": 7955, "uniprot_kb": "A0A0H2UKN7"}, {"ZFIN": "ZDB-GENE-060503-604", "ortholog_type": "O", "panther_family": "PTHR10546", "taxid": 7955, "uniprot_kb": "Q06W32"}], "uniprot_kb": "Q07699"}, "pathway": {"kegg": {"id": "hsa04261", "name": "Adrenergic signaling in cardiomyocytes - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-373760", "name": "L1CAM interactions"}, {"id": "R-HSA-397014", "name": "Muscle contraction"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-445095", "name": "Interaction between L1 and Ankyrins"}, {"id": "R-HSA-5576891", "name": "Cardiac conduction"}, {"id": "R-HSA-5576892", "name": "Phase 0 - rapid depolarisation"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9709957", "name": "Sensory Perception"}, {"id": "R-HSA-9717189", "name": "Sensory perception of taste"}, {"id": "R-HSA-9717207", "name": "Sensory perception of sweet, bitter, and umami (glutamate) taste"}], "smpdb": [{"id": "SMP00392", "name": "Benzocaine Action Pathway"}, {"id": "SMP00393", "name": "Bupivacaine Action Pathway"}, {"id": "SMP00394", "name": "Chloroprocaine Action Pathway"}, {"id": "SMP00395", "name": "Cocaine Action Pathway"}, {"id": "SMP00396", "name": "Dibucaine Action Pathway"}, {"id": "SMP00397", "name": "Levobupivacaine Action Pathway"}, {"id": "SMP00398", "name": "Lidocaine (Local Anaesthetic) Action Pathway"}, {"id": "SMP00399", "name": "Mepivacaine Action Pathway"}, {"id": "SMP00400", "name": "Oxybuprocaine Action Pathway"}, {"id": "SMP00401", "name": "Prilocaine Action Pathway"}, {"id": "SMP00402", "name": "Procaine Action Pathway"}, {"id": "SMP00403", "name": "Proparacaine Action Pathway"}, {"id": "SMP00404", "name": "Ropivacaine Action Pathway"}, {"id": "SMP00405", "name": "Codeine Action Pathway"}, {"id": "SMP00406", "name": "Morphine Action Pathway"}, {"id": "SMP00407", "name": "Heroin Action Pathway"}, {"id": "SMP00408", "name": "Methadone Action Pathway"}, {"id": "SMP00409", "name": "Oxycodone Action Pathway"}, {"id": "SMP00410", "name": "Hydromorphone Action Pathway"}, {"id": "SMP00411", "name": "Hydrocodone Action Pathway"}, {"id": "SMP00412", "name": "Oxymorphone Action Pathway"}, {"id": "SMP00413", "name": "Alfentanil Action Pathway"}, {"id": "SMP00414", "name": "Carfentanil Action Pathway"}, {"id": "SMP00415", "name": "Fentanyl Action Pathway"}, {"id": "SMP00416", "name": "Remifentanil Action Pathway"}, {"id": "SMP00417", "name": "Sufentanil Action Pathway"}, {"id": "SMP00422", "name": "Imipramine Action Pathway"}, {"id": "SMP00423", "name": "Desipramine Action Pathway"}, {"id": "SMP00424", "name": "Citalopram Action Pathway"}, {"id": "SMP00425", "name": "Escitalopram Action Pathway"}, {"id": "SMP00426", "name": "Fluoxetine Action Pathway"}, {"id": "SMP00431", "name": "Nicotine Action Pathway"}, {"id": "SMP00620", "name": "Lidocaine (Local Anaesthetic) Metabolism Pathway"}, {"id": "SMP00671", "name": "Tramadol Action Action Pathway"}, {"id": "SMP00672", "name": "Propoxyphene Action Pathway"}, {"id": "SMP00673", "name": "Levorphanol Action Pathway"}, {"id": "SMP00674", "name": "Anileridine Action Pathway"}, {"id": "SMP00675", "name": "Diphenoxylate Action Pathway"}, {"id": "SMP00676", "name": "Dezocine Action Pathway"}, {"id": "SMP00677", "name": "Levomethadyl Acetate Action Action Pathway"}, {"id": "SMP00678", "name": "Methadyl Acetate Action Pathway"}, {"id": "SMP00679", "name": "3-Methylthiofentanyl Action Pathway"}, {"id": "SMP00680", "name": "Dimethylthiambutene Action Pathway"}, {"id": "SMP00681", "name": "Ethylmorphine Action Pathway"}, {"id": "SMP00683", "name": "Levallorphan Action Pathway"}, {"id": "SMP00684", "name": "Buprenorphine Action Pathway"}, {"id": "SMP00685", "name": "Alvimopan Action Pathway"}, {"id": "SMP00686", "name": "Pentazocine Action Pathway"}, {"id": "SMP00687", "name": "Naltrexone Action Pathway"}, {"id": "SMP00688", "name": "Naloxone Action Pathway"}, {"id": "SMP00689", "name": "Dihydromorphine Action Pathway"}, {"id": "SMP00690", "name": "Ketobemidone  Action Pathway"}, {"id": "SMP00691", "name": "Nalbuphine Action Pathway"}]}, "pdb": ["6AGF", "6J8G", "6J8H", "6J8I", "6J8J", "7W77", "7W7F", "7W9K", "7W9L", "7W9M", "7W9P", "7W9T", "7XM9", "7XMF", "7XMG", "7XVE", "7XVF", "8FHD", "8G1A", "8GZ1", "8GZ2", "8I5B", "8I5G", "8I5X", "8I5Y", "8J4F", "8S9B", "8S9C", "8THG", "8THH", "8XMM", "8XMN", "8XMO"], "pfam": "PF07686", "pharmgkb": "PA302", "pharos": {"target_id": 11128, "tdl": "Tbio"}, "pir": "A55734", "prosite": "PS51257", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF256007", "relationship": "is"}, {"id": "GNF256008", "relationship": "is"}, {"id": "GNF256009", "relationship": "is"}, {"id": "GNF256010", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF158396", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF040370", "relationship": "similar to"}, {"id": "GNF048138", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF090807", "relationship": "is"}, {"id": "GNF090808", "relationship": "is"}, {"id": "GNF090809", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052835", "relationship": "is"}, {"id": "GNF057601", "relationship": "is"}, {"id": "GNF072707", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070135", "relationship": "is"}, {"id": "GNF070136", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF013049", "relationship": "is"}, {"id": "GNF017866", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF105694", "relationship": "is"}, {"id": "GNF145340", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NG_013359.1"], "protein": ["NP_001028.1", "NP_001308534.1", "NP_950238.1"], "rna": ["NM_001037.5", "NM_001321605.2", "NM_199037.5"], "translation": [{"protein": "NP_950238.1", "rna": "NM_199037.5"}, {"protein": "NP_001308534.1", "rna": "NM_001321605.2"}, {"protein": "NP_001028.1", "rna": "NM_001037.5"}]}, "reporter": {"HG-U133_Plus_2": "205508_at", "HG-U95Av2": "38516_at", "HTA-2_0": "TC19000455.hg.1", "HuEx-1_0": "3830051", "HuGene-1_1": "8027719", "HuGene-2_1": "16860856"}, "summary": "Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009].", "symbol": "SCN1B", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1419857"}, "unigene": "Hs.436646", "uniprot": {"Swiss-Prot": "Q07699", "TrEMBL": ["B4DI92", "A0A1W2PR05", "A0A6Q8PHF7", "A0A6Q8PGS1", "A0A1W2PS68"]}, "wikipedia": {"url_stub": "SCN1B"}}